CustomerValidation
- •NatCommun.2017May22;8:15398.
- •Elife.2016Apr11;5.pii:e14087.
- •Oncotarget.2017Sep23;8(49):86395-86409.
- •Oncotarget.2016Oct4;7(40):66087-66099.
- •Oncotarget.2016Jun14;7(24):35643-35654.
- •AmJPhysiolLungCellMolPhysiol.2017Jul1;313(1):L104-L114.
- •Virology.2015Mar;477:10-7.
- •AnnHematol.2014Sep;93(9):1499-508.
- •BiochemBiophysResCommun.2017Jan29;483(1):223-229.
- •TechnolCancerResTreat.2016Aug;15(4):527-34.
- •UlmUniversity.13-01-2017.
| Description | MLN4924isapotentandselectiveNEDD8-activatingenzyme(NAE)inhibitorwithIC50of4.7nM. |
|---|---|
| IC50&Target | IC50:4.7nM(NAE)[1] |
| InVitro | MLN4924isapotentinhibitorofNAE,andisselectiverelativetothecloselyrelatedenzymesUAE,SAE,UBA6andATG7(IC50=1.5,8.2,1.8and>10μM,respectively)whenevaluatedinpurifiedenzymeassaysthatmonitortheformationofE2-UBLthioesterreactionproducts.MLN4924selectivelyinhibitsNAEactivitycomparedtothecloselyrelatedubiquitin-activatingenzyme(UAE,alsoknownasUBA1)andSUMO-activatingenzyme(SAE;aheterodimerofSAE1andUBA2subunits),inpurifiedenzymeandcellularassays.MLN4924exhibitspotentcytotoxicactivityagainstavarietyofhumantumour-derivedcelllines[1]. |
| InVivo | MLN4924(sc,10mg/kg,30mg/kg,or60mg/kg)inhibitstheNEDD8pathwayresultinginDNAdamageinMicebearingHCT-116xenografts[1].Pevonedistat(sc,120mg/kg)andTNF-α(10μg/kg)synergisticallycauseliverdamageinSDrats[2]. |
| ClinicalTrial | ViewMoreCollapse |
| References |
|
| PreparingStockSolutions |
Pleaserefertothesolubilityinformationtoselecttheappropriatesolvent. | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CellAssay [1] | MLN4924isdissolvedinDMSOandstored,andthendilutedwithappropriatemediumbeforeuse[1]. HCT-116cellsgrownin6-wellcell-culturedishesaretreatedwith0.1%DMSO(control)or0.3μMMLN4924for24h.Wholecellextractsarepreparedandanalysedbyimmunoblotting.ForanalysisoftheE2-UBLthioesterlevels,lysatesarefractionatedbynon-reducingSDS-PAGEandimmunoblottedwithpolyclonalantibodiestoUbc12,Ubc9andUbc10.Foranalysisofotherproteins,lysatesarefractionatedbyreducingSDS-PAGEandprobedwithprimaryantibodiesasfollows:mousemonoclonalantibodiestoCDT1,p27,geminin,ubiquitin,securin/PTTGandp53orrabbitpolyclonalantibodiestoNRF2,CyclinB1andGADD34[1].MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly. | ||||||||||||||||
| AnimalAdmiNISTration [1][2] | MLN4924isdissolvedinDMSOandthendilutedwithPBSorsaline. Mice[1] | ||||||||||||||||
| References |
|
| MolecularWeight | 443.52 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Formula | C₂₁H₂₅N₅O₄S | ||||||||||||
| CASNo. | 905579-51-3 | ||||||||||||
| Storage |
| ||||||||||||
| Shipping | RoomtemperatureincontinentalUS;mayvaryelsewhere | ||||||||||||
| Solvent&Solubility | DMSO:≥111.25mg/mL *"<1 mg/ml"="" means="" slightly="" soluble="" or="" insoluble.="" "≥"="" means="" soluble,="" but="" saturation="">1> Purity:98.00%
|




